1. Home
  2. KLXE vs KPTI Comparison

KLXE vs KPTI Comparison

Compare KLXE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$2.79

Market Cap

45.6M

Sector

Energy

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$9.05

Market Cap

194.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
KPTI
Founded
2018
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
194.8M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
KLXE
KPTI
Price
$2.79
$9.05
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.00
AVG Volume (30 Days)
299.9K
466.1K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$636,600,000.00
$146,067,000.00
Revenue This Year
$3.89
N/A
Revenue Next Year
$4.95
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$1.46
$3.65
52 Week High
$4.50
$10.99

Technical Indicators

Market Signals
Indicator
KLXE
KPTI
Relative Strength Index (RSI) 42.17 54.69
Support Level $2.65 $5.43
Resistance Level $3.10 $9.45
Average True Range (ATR) 0.31 0.73
MACD -0.07 0.05
Stochastic Oscillator 6.47 70.29

Price Performance

Historical Comparison
KLXE
KPTI

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: